For the last decade Optalert’s focus has been driver drowsiness. We are now turning our attention to other health conditions and have developed an AI-based model that tests for obstructive sleep apnoea (OSA). The condition affects 13.2% of the world’s population and it is chronically underdiagnosed: 80% of people with OSA never undergo diagnosis or...

Introduction Artificial intelligence (AI) is a hot topic. Amid all the noise about generative AI tools like ChatGPT and MidJourney, the myriad of other powerful AI applications has been drowned out. One such shift we foresee is that of health monitoring via the PC webcam. Enabled by increasingly powerful graphical processing units (GPUs) and tensor...

Obstructive sleep apnoea (OSA) affects 425 million people globally at a mild to severe level requiring treatment, but over 80% of them remain undiagnosed. Optalert’s technology can now alert the 92 million people in Europe, 24 million in the USA, and 309 million across the rest of the world with undiagnosed OSA to seek diagnosis...

Optalert has more than 20 years’ expertise in drowsiness, developed primarily in its work for the mining industry, wherein the equipment and vehicles; the payloads; the operator cognitive loads; and the consequences of an accident caused by drowsiness are all enormous. That’s the demanding environment in which Optalert has grown its know-how. Follow the link...

Optalert, the world’s leader in drowsiness and alertness detection, today welcomed Professor Matthew Kiernan as a new Non- Executive Director of its board. Professor Matthew Kiernan is Co-Director of the Brain and Mind Centre, focusing on discovery and translation and President of the Brain Foundation, funding world-class research into neurological disorders, brain disease and brain...

Tuesday, 14 September 2021 Optalert, the world’s leader in drowsiness and alertness detection, today appointed Non-executive Director Ms Christine Cussen to its board.  Ms Cussen has a long and distinguished career with decades of executive and board experience across diverse industry sectors in listed, private and government sectors including global pharmaceutical, biotechnology, medical, industrial, and...

Motor racing is both a physically challenging and mentally demanding sport.  Its associated with a high degree of safety risk for drivers, whereby the slightest error could lead to fatal consequences.   Drowsiness and inattentiveness are amongst the most dangerous risks faced by any driver, yet alone a race car driver who’s preparing to be at...

2020 will go down as one of the most difficult for companies and leaders around the world.  The corona virus has taken lives, isolated families, closed airports and put a fear into many like never before.  Whilst most of us have had the privilege of a stable life occupied with routine, the future is now...

Optalert’s sophisticated software algorithm, leads the drowsiness monitoring field, by providing the next level layer within driver monitoring systems (DMS).  Optalert’s scientifically validated Johns Drowsiness Scale (JDSTM) enables an objective, real time, quantifiable measure of drowsiness.  Applicable across ethnicity, gender and age, the JDS™ empowers the driver with the ability to avoid dangerous microsleeps.  Providing...

September is World Alzheimer’s month, the international campaign which raises awareness and challenges the stigma that surrounds dementia. Around the world 50 million people have dementia, and each year there are nearly 10 million new cases. The total number of people with dementia is projected to reach 82 million by 2030! With over 100 forms...